Radiopharm Theranostics Limited

RADXNASDAQ Capital Market·USD·Closed

RADXNASDAQ·USD·Closed

$3.15

−1.56%

$3.15

−$0.05 (1.56%)

52W Range

3thpctl

Volume

1.49×avg

Mkt Cap

4.06MUSD

P/E

-0.9TTM

Div Yield

–ann

Healthcare · Biotechnology

52W Range

3thpctl

Volume

1.49×avg

Market Cap

4.06MUSD

P/E Ratio

-0.9TTM

Div Yield

-ann

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth+1114.3% / yr

Operating margin-402.8%

ROIC-59.9%

Financially safe

Stretched

Debt / equity0.00×

Interest coverage-380.6×

Current ratio3.01×